"The Life Sciences market is a key growth opportunity for FEI," noted Don Kania, president and CEO of FEI. "With this acquisition, FEI acquires additional key technology for correlative microscopy for cellular biology, which integrates high performance light and electron microscopy. Now we can accelerate the growth of our Life Sciences business, which is an important component of our company-wide plan to double our served available market in the next three years."
"The very open and flexible microscope platforms of TILL are an ideal starting point for correlative microscopy," commented Frank Lison, president of TILL Photonics GmbH. "They will open up new market opportunities for our high-resolution technologies. The strength of FEI will help us to achieve our goals much faster."
The purchase price for the acquisition is EURO14.5 million (approximately $20 million), plus an earn-out payable in two years based on attainment of specified milestones. TILL brings great products, a wealth of technology and a skilled and experienced team to FEI, along with revenues of approximately $8 million for calendar year 2011.